Clinical Trials Browser

Phase 1 × Epirubicin × Gastrointestinal × Clear all

NCT00486356 2024-01-03

Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic Cancer

Phase 1 Completed

Gastrointestinal

Bile Duct Neoplasms, Gallbladder Neoplasms, Carcinoma, Hepatocellular, Liver Neoplasms, Stomach Neoplasms

NCT01386346 2018-12-12

VEOX

Phase 1 Completed

Gastrointestinal

Esophageal Neoplasms